Medicare Enrolled
Dr. Salman Azam, M.D.
Interventional Cardiology · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Azam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Azam
Dr. Salman Azam is an interventional cardiology specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Azam performed 1,840 Medicare services across 920 unique beneficiaries.
Between the years covered by Open Payments, Dr. Azam received a total of $203,796 from 31 pharmaceutical and/or device companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Azam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ 1,840 Medicare services
$203,796 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,840
Medicare services
Bottom 42% in CA for interventional cardiology
920
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
451 | $72 | $200 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
192 | $45 | $146 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
179 | $52 | $100 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
157 | $42 | $114 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
139 | $114 | $295 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
131 | $64 | $142 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
116 | $54 | $333 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
108 | $6 | $45 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
86 | $41 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
59 | $33 | $92 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
47 | $7 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $125 | $386 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $285 | $628 |
| New patient office visit, complex (60-74 min) | 20 | $146 | $418 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $20 | $156 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
17 | $629 | $1,900 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
14 | $58 | $250 |
| Mitral valve repair through skin, initial prosthesis A minimally invasive procedure to repair the mitral valve using a new prosthetic device inserted through the skin. |
13 | $1,446 | $4,000 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
11 | $604 | $3,500 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
11 | $18 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $12 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.6% high complexity
2.9% medium
89.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$203,796
Total received (2018-2024)
Avg $29,114/year across 7 years
Top 6% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
611
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$194,793 (95.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,002 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37,244
2023
$51,125
2022
$36,500
2021
$31,864
2020
$5,834
2019
$19,275
2018
$21,953
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$35,437
Abbott Laboratories
$525
Boston Scientific Corporation
$365
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$205
PFIZER INC.
$119
Novartis Pharmaceuticals Corporation
$115
Kiniksa Pharmaceuticals International, plc
$96
Janssen Pharmaceuticals, Inc
$93
Medtronic, Inc.
$70
SCPHARMACEUTICALS INC.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
iRhythm Technologies, Inc.
$36
Alnylam Pharmaceuticals Inc.
$25
Amgen Inc.
$17
Kestra Medical Technology Services, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 97.5% of 2024 payments
All-time payments by company (2018-2024) ›
Edwards Lifesciences Corporation
$194,793
Boston Scientific Corporation
$2,502
Abbott Laboratories
$1,454
Medtronic, Inc.
$819
Novartis Pharmaceuticals Corporation
$620
Janssen Pharmaceuticals, Inc
$572
Medtronic Vascular, Inc.
$414
PFIZER INC.
$396
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$382
Philips Electronics North America Corporation
$215
AstraZeneca Pharmaceuticals LP
$209
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Amgen Inc.
$173
SANOFI-AVENTIS U.S. LLC
$165
ABIOMED
$162
E.R. Squibb & Sons, L.L.C.
$105
Kiniksa Pharmaceuticals International, plc
$96
Chiesi USA, Inc.
$84
SCPHARMACEUTICALS INC.
$68
Actelion Pharmaceuticals US, Inc.
$54
iRhythm Technologies, Inc.
$47
Alnylam Pharmaceuticals Inc.
$43
Kiniksa Pharmaceuticals, Ltd.
$39
Terumo Medical Corporation
$38
Novo Nordisk Inc
$33
BOSTON SCIENTIFIC CORPORATION
$24
GE HealthCare
$23
Regeneron Healthcare Solutions, Inc.
$19
Astellas Pharma US Inc
$14
Kestra Medical Technology Services, Inc.
$14
BSN Medical Inc
$13
Top 3 companies account for 97.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMPLATZER PICCOLO · AMVUTTRA · AVVIGO Guidance System · AZURE XT DR MRI SURESCAN · Arcalyst · Assure WCD · Azure · BRILINTA · BodyGuardian · CAMZYOS · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · CLEVIPREX · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CUTIMED SORBACT · CardioMEMS HF System · CareLink Express · Claria MRI · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · GENERAL - STRUCTURAL HEART · GENERAL STENTS · GUIDEZILLA · Heartrail · Impella · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LifeVest · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · NA · NAVITOR · ONPATTRO · OPSUMIT · Optis Coronary Imaging System · Ozempic · PASCAL · PRADAXA · PRALUENT · Pipeline · Repatha · SAPIEN 3 Ultra RESILIA · STEALTHSTATION S8 PLATFORM · Sentinel · Trilogy 100 · VYNDAQEL · WATCHMAN · WATCHMAN FLX · XARELTO · Xience Alpine cornary stent system · ZIO Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for interventional cardiology in CA.
Geographic Context
Interventional cardiologists within 10 mi
81
Per 100K population
0.8
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Azam is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 6% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Azam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Azam performed 451 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azam receive payments from pharmaceutical companies?
Yes. Dr. Azam received a total of $203,796 from 31 companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azam's costs compare to other interventional cardiologists in Torrance?
Dr. Azam's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Torrance
Browse interventional cardiologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology